Harlingen Medical Center & Texas State Technical College Team Up to Raise Awareness for Celiac Disease

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

About the Event

Harlingen Medical Center (HMC) & Texas State Technical College (TSTC) are teaming up to promote health and wellness and raise awareness of Celiac Disease – with the first HMC & TSTC Celiac Disease Awareness 5k Run/1m Walk.  The goal with the run-walk is to bring education to the residents of South Texas regarding the health-related risks linked to celiac disease, which is a genetic autoimmune disorder where the ingestion of gluten leads to possible damage in the small intestine.

The Run/Walk

- Advertisement -

The Run-Walk is OPEN TO THE COMMUNITY!  It will feature complimentary basic medical screenings, health and wellness education, a Zumba-warm-up session prior to the run/walk, an Education Expo with demonstrations on healthy meal preparation, gluten-free food options, education on celiac disease, Doc Talk Lectures featuring expert presentations on healthy-living, fun activities for young children, and much more! 

Registration is NOW OPEN

To register as a participant of the Run-Walk, you may do so by downloading the attached Participant Registration Form and returning to the Marketing Office at Harlingen Medical Center (located inside the Administration Offices), with payment; or, you may register on-line at:https://www.eventbrite.com/e/harlingen-medical-center-tstc-1st-annual-celiac-disease-awareness-run-walk-tickets-33446274708.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -